Latest Insider Transactions at Alexion Pharmaceuticals, Inc. (ALXN)
This section provides a real-time view of insider transactions for Alexion Pharmaceuticals, Inc. (ALXN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ALEXION PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ALEXION PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2020
|
Aradhana Sarin EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
15,371
+23.94%
|
-
|
|
Dec 16
2020
|
John J Orloff EVP, Research & Development |
SELL
Payment of exercise price or tax liability
|
Direct |
21,395
-13.07%
|
$3,359,015
$157.96 P/Share
|
|
Dec 16
2020
|
John J Orloff EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
40,677
+32.31%
|
-
|
|
Dec 16
2020
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,838
-15.74%
|
$3,114,566
$157.96 P/Share
|
|
Dec 16
2020
|
Indrani Lall Franchini EVP, Chief Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,965
+36.45%
|
-
|
|
Dec 16
2020
|
Brian Goff EVP & Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,395
-12.53%
|
$3,359,015
$157.96 P/Share
|
|
Dec 16
2020
|
Brian Goff EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
40,677
+31.44%
|
-
|
|
Dec 16
2020
|
Daniel Bazarko SVP, Controller, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,812
-11.57%
|
$1,383,484
$157.96 P/Share
|
|
Dec 16
2020
|
Daniel Bazarko SVP, Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
15,371
+27.91%
|
-
|
|
Dec 16
2020
|
Ludwig Hantson CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
85,592
-12.59%
|
$13,437,944
$157.96 P/Share
|
|
Dec 16
2020
|
Ludwig Hantson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
162,707
+31.53%
|
-
|
|
Dec 15
2020
|
Ellen Chiniara EVP & Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56
+0.13%
|
$5,320
$95.53 P/Share
|
|
Dec 15
2020
|
John J Orloff EVP, Research & Development |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.06%
|
$3,720
$93.53 P/Share
|
|
Dec 03
2020
|
Tanisha Carino EVP & CCAO |
SELL
Open market or private sale
|
Direct |
1,530
-8.68%
|
$186,660
$122.26 P/Share
|
|
Dec 02
2020
|
Tanisha Carino EVP & CCAO |
SELL
Payment of exercise price or tax liability
|
Direct |
665
-3.63%
|
$80,465
$121.76 P/Share
|
|
Nov 30
2020
|
Aradhana Sarin EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,298
-3.73%
|
$160,952
$124.0 P/Share
|
|
May 14
2020
|
Baker Bros. Advisors LP Director |
BUY
Grant, award, or other acquisition
|
Indirect |
9,314
+0.13%
|
-
|
|
Mar 18
2020
|
Baker Bros. Advisors LP Director |
BUY
Open market or private purchase
|
Indirect |
132,281
+0.12%
|
$10,714,761
$81.04 P/Share
|
|
Mar 17
2020
|
Baker Bros. Advisors LP Director |
BUY
Open market or private purchase
|
Indirect |
102,421
+0.35%
|
$7,886,417
$77.14 P/Share
|
|
Mar 16
2020
|
Baker Bros. Advisors LP Director |
BUY
Open market or private purchase
|
Indirect |
265,298
+0.54%
|
$20,693,244
$78.08 P/Share
|
|
May 30
2019
|
Baker Bros. Advisors LP Director |
SELL
Open market or private sale
|
Indirect |
57,449
-0.22%
|
$6,951,329
$121.07 P/Share
|
|
May 29
2019
|
Baker Bros. Advisors LP Director |
SELL
Open market or private sale
|
Indirect |
119,062
-0.46%
|
$14,525,564
$122.27 P/Share
|
|
May 28
2019
|
Baker Bros. Advisors LP Director |
SELL
Open market or private sale
|
Indirect |
123,489
-0.47%
|
$15,559,614
$126.12 P/Share
|
|
May 15
2019
|
Baker Bros. Advisors LP Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,452
+0.16%
|
-
|
|
May 09
2018
|
Baker Bros. Advisors LP Director |
BUY
Grant, award, or other acquisition
|
Indirect |
4,348
+0.12%
|
-
|